首页 | 本学科首页   官方微博 | 高级检索  
检索        

高浓度大剂量局部灌注给药治疗耐多药肺结核
引用本文:张耀亭,杨柳,张清华,杨妙枝.高浓度大剂量局部灌注给药治疗耐多药肺结核[J].中国防痨通讯,2004,26(2):89-91.
作者姓名:张耀亭  杨柳  张清华  杨妙枝
作者单位:1.福建省漳州解放军第一七五医院 漳州 363000;
摘    要:目的 探讨经纤支镜高浓度大剂量药物灌注治疗耐多药肺结核的疗效及安全性。方法 将 60例耐多药肺结核随机分为治疗组和对照组,治疗组强化期第 1月经纤支镜高浓度大剂量左氧氟沙星(0.2%,60~120mL)病灶灌注加全身化疗,对照组强化期第 1、2月经纤支镜常规浓度剂量左氧氟沙星 (0.1%,10~20mL)病灶灌注加化疗。结果 强化期结束时,治疗组痰菌阴转率 96.7% (2930),病灶显著吸收率 83.3% (2530),明显高于对照组的 73.3% (2230)和 53.3% (1630) (P均<0.05)。痰菌阴转平均时间治疗组 32.5d,比对照组 56.5d明显缩短 (P<0.01)。结论 经纤支镜高浓度大剂量局部灌注给药治疗耐多药肺结核,疗效优于常规灌注,且疗程短、费用低、无并发症,安全可行。

关 键 词:结核    耐多药  纤维支气管镜  导管插入术  灌注治疗  
修稿时间:2002年4月29日

High concentration and large dose perfusion on treatment of multi-drug resistance pulmonary tuberculosis
Zhang Yaoting,Yan Liu,Zhang Qinhua,et al..High concentration and large dose perfusion on treatment of multi-drug resistance pulmonary tuberculosis[J].The Journal of The Chinese Antituberculosis Association,2004,26(2):89-91.
Authors:Zhang Yaoting  Yan Liu  Zhang Qinhua  
Institution:Department of Pulmonary Medicine,175th Hospital of P L A,Zhangzhou 363000
Abstract:Objective To evaluate the clinical value and safety of high concentration and large dose perfusion on treatment of multi drug res istance pulmonary tuberculosis.Methods Sixty patients with multi drug resistant pulmonary tub erculosis cases were randomly divided into an experiment and control group.The experiment group was treated by perfusion with levofloxacin (0.2%,60~120 mL) and general antituberculosis chemotherapy.The control group was treated by injecting levofloxacin (0.1%,10~20 mL) and general antituberculosis chemotherapy. Results At the end initial phase of treatment,the sputum conversion rate was 96.7%,foci marked absorption rate was 83.3% in the experiment group,all of which were higher than that of the control’s (73.3% and 53.3% respectively, P<0.05).Sputum conversion time (32.5 d) in the experiment group was shorter than that of the controls (56.5 d)(P<0.01). Conclusion The efficacy of the high concentration and large dose perfusion is better than the routine injection in the treatment of multi drug resistance pulmonary tuberculosis.The treatment course was shorted.The expense was lower.No complication and obvious adverse reaction were observed.
Keywords:Tuberculosis  pulmonary  Multidrug  resistant  Bronchof iberscope  Catheterization  Perfusion therapy
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《中国防痨通讯》浏览原始摘要信息
点击此处可从《中国防痨通讯》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号